Merck Shares Reach New Highs Driven by Strong Cancer Drug Sales

Rahway, Wednesday, 19 August 2026.
Merck stock hit a 52-week high in August 2026, supported by robust oncology revenue and a 70% annual gain, demonstrating strong investor confidence in its long-term product pipeline.